Exact Mass: 529.082217

Exact Mass Matches: 529.082217

Found 23 metabolites which its exact mass value is equals to given mass value 529.082217, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

dTDP-3-amino-2,3,6-trideoxy-D-threo-hexopyranos-4-ulose

dTDP-3-amino-2,3,6-trideoxy-4-keto-D-glucose; dTDP-3-amino-2,3,6-trideoxy-D-threo-hexopyranos-4-ulose; dTDP-3-amino-4-oxo-2,3,6-trideoxy-D-glucose

C16H25N3O13P2 (529.086258)


   

dTDP-3-amino-4,6-deoxy-3,4-dehydroglucose

dTDP-3-amino-4,6-dideoxy-3,4-dehydroglucose

C16H25N3O13P2 (529.086258)


   

dTDP-4-(methylamino)-2,3,4,6-tetradeoxy-alpha-D-glucose

dTDP-4-(methylamino)-2,3,4,6-tetradeoxy-D-glucose; dTDP-4-(methylamino)-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranose

C17H29N3O12P2 (529.1226414)


A pyrimidine nucleotide-sugar having thymine as the nucleobase and 4-(methylamino)-2,3,4,6-tetradeoxy-alpha-D-glucose as the sugar component.

   

dTDP-3-amino-4-oxo-2,3,6-trideoxy-L-allose

dTDP-3-amino-4-oxo-2,3,6-trideoxy-L-allose

C16H25N3O13P2 (529.086258)


   

Dragmacidin E

(-)-Dragmacidin E

C25H20BrN7O2 (529.086176)


   
   

2-Hydroxytenoxicam glucuronide

2-Hydroxytenoxicam glucuronide

C19H19N3O11S2 (529.0460984)


   

Hydroxytenoxicam glucuronide

Hydroxytenoxicam glucuronide

C19H19N3O11S2 (529.0460984)


   
   

Cefoperazone Impurity A

Cefoperazone Impurity A

C23H23N5O8S (529.1267278)


   
   

(2R)-1-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]-2-(diphenylphosphino)-Ferrocene

(2R)-1-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]-2-(diphenylphosphino)-Ferrocene

C32H28FeNOP (529.1257798)


   

(2S)-1-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]-2-(diphenylphosphino)-Ferrocene

(2S)-1-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]-2-(diphenylphosphino)-Ferrocene

C32H28FeNOP (529.1257798)


   

(3R,4S,5R,6R)-6-(acetoxyMethyl)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triyl

(3R,4S,5R,6R)-6-(acetoxyMethyl)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triyl

C27H26FO4S 3* (529.0977188)


   
   

1-Cyclopropyl-7-[4-(2,3-dihydro-1,4-benzodioxine-6-sulfonyl)piperazin-1-yl]-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

1-Cyclopropyl-7-[4-(2,3-dihydro-1,4-benzodioxine-6-sulfonyl)piperazin-1-yl]-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C25H24FN3O7S (529.1318926)


   

CDP-3,6-dideoxy-D-glycero-D-glycero-4-hexulose

CDP-3,6-dideoxy-D-glycero-D-glycero-4-hexulose

C15H21N3O14P2-2 (529.0498746000001)


   
   
   

[(2R,4S,6S)-4-amino-6-methyl-5-oxooxan-2-yl] [hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate

[(2R,4S,6S)-4-amino-6-methyl-5-oxooxan-2-yl] [hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate

C16H25N3O13P2 (529.086258)


   
   
   

Nebentan (potassium)

Nebentan (potassium)

C24H20KN5O5S (529.082217)


Nebentan potassium (YM598) is a potent, selective and orally active non-peptide endothelin ETA receptor antagonist through the modification of Bosentan (HY-A0013). Nebentan potassium inhibits [125I] endothelin-1 binding to cloned human endothelin ETA and ETB receptor, with Ki of 0.697 nM and 569 nM, respectively[1]. YM598 can ameliorate the progression of cor pulmonale and myocardial infarction in vivo[2].